Article
A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer
20 Mar 2020
Abstract excerpt
BACKGROUND: Gastric cancer (GC) is the fifth most frequently diagnosed cancer and the third leading cause of cancer-related mortality. Lack of prognostic indicators for patient survival hinders GC treatment and survival. METHODS AND RESULTS: Methylation profile data of patients with GC obtained from The Cancer Genome Atlas (TCGA) database were analyzed to identify methylation sites as biomarkers for GC prognosis....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
